Revenues for the third quarter of fiscal 2009 were $115.17 million, a 2.9% increase, compared to $111.93 million for the same period of fiscal 2008.
Net income for the first nine months of fiscal 2009 was $67.22 million, or $3.48 per diluted share, compared to $49.57 million, or $2.56 per diluted share, for the corresponding period of fiscal 2008. For the first nine months of fiscal 2009, revenues were $353.09 million, compared to $349.42 million in the corresponding period of fiscal 2008, representing a 1.1% increase.
Zan Guerry, chairman and CEO of Chattem, said: "The strength of Gold Bond, ACT, Icy Hot and Cortizone-10 and the successes of our 2009 new product launches for these brands produced another period of strong earnings and operating results.
"The company's domestic business, representing 95% of our total revenues, achieved growth of 3.9% and 3.5% over the year ago nine and three month periods, respectively, when excluding the discontinued Icy Hot Heat Therapy product from the first quarter of fiscal 2008."
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index